1-20 of 36
Yongxian Hu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and safety of CD19-specific CAR T cell–based therapy in B-cell acute lymphoblastic leukemia patients with CNSL

Clinical Trials & Observations
Yuekun Qi, Mingfeng Zhao, Yongxian Hu, Ying Wang, Ping Li, Jiang Cao, Ming Shi, Jiaqi Tan, Meng Zhang, Xia Xiao, Jieyun Xia, Sha Ma, Jianlin Qiao, Zhiling Yan, Hujun Li, Bin Pan, Wei Sang, Depeng Li, Zhenyu Li, Jianfeng Zhou, He Huang, Aibin Liang, Junnian Zheng, Kailin Xu
Journal: Blood
Blood (2022) 139 (23): 3376–3386.
DOI: https://doi.org/10.1182/blood.2021013733
Published: 2022
Includes: Supplemental data
Journal Articles

Predictive Value of Next-Generation Sequencing-Based Minimal Residual Disease after CAR-T Cell Therapy

Yue Huang, Houli Zhao, Mi Shao, Linghui Zhou, Guoqing Wei, Wenjun Wu, Alex Hong Chang, Tao Sun, Yongxian HU, He Huang
Journal: Blood
Blood (2021) 138 (Supplement 1): 2842.
DOI: https://doi.org/10.1182/blood-2021-149928
Published: 2021
Journal Articles

A Phase 1/2 Study of a Novel Fully Human B-Cell Maturation Antigen-Specific CAR T Cells (CT103A) in Patients with Relapsed and/or Refractory Multiple Myeloma

Chunrui Li, Di Wang, Yongping Song, Jianyong Li, He Huang, Bing Chen, Jing Liu, Kai Hu, Hanyun Ren, Xi Zhang, Zhenyu Li, Dehui Zou, Qingsong Yin, Lijuan Chen, Yongxian HU, Yong Xu, Qian Cheng, Yuelu Guo, Yujun Dong, Li Gao, Aining Xu, Songbai Cai, Wen Wang, Ming Wu, Jue Wang, Liting Chen, Jianfeng Zhou, Lugui Qiu
Journal: Blood
Blood (2021) 138 (Supplement 1): 547.
DOI: https://doi.org/10.1182/blood-2021-152576
Published: 2021
Journal Articles

Venetoclax-Ponatinib for T315I/Compound-Mutated Ph+Acute Lymphoblastic Leukemia

Huafeng Wang, Jiejing Qian, Chang Yang, Yi Zhang, Yungui Wang, Ting Shi, Yongxian HU, Liping Mao, Xiujin Ye, Fang Liu, Zhenfang Xi, Lihong Shou, Caiyun Fu, Hua Naranmandura, Jie Jin, Hong-Hu Zhu
Journal: Blood
Blood (2021) 138 (Supplement 1): 3395.
DOI: https://doi.org/10.1182/blood-2021-152836
Published: 2021
Journal Articles

Clinical Characterization and Risk Factors Associated with Cytokine Release Syndrome Induced By COVID-19 and Chimeric Antigen Receptor T-Cell Therapy

Ruimin Hong, Houli Zhao, MD, Yiyun Wang, Yu Chen, Hongliu Cai, Yongxian Hu, MD, Guoqing Wei, MD, He Huang, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 35–36.
DOI: https://doi.org/10.1182/blood-2020-139007
Published: 2020
Journal Articles

The Safety and Efficacy of a CRISPR/Cas9-Engineered Universal CAR-T Cell Product (CTA101) in Patients with Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia

Yongxian Hu, MD, Yali Zhou, Mingming Zhang, MD, Wengang Ge, Yi Li, MD, Li Yang, MD, Guoqing Wei, MD, Lu Han, Hao Wang, Xingwang Zhang, PhD, Jiangtao Ren, PhD, He Huang, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 52.
DOI: https://doi.org/10.1182/blood-2020-142262
Published: 2020
Journal Articles

CD19/CD22 Dual-Targeted Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Aggressive B-Cell Lymphoma: a Safety and Efficacy Study

Yongxian Hu, MD, Yanlei Zhang, Houli Zhao, MD, Yiyun Wang, Arnon Nagler, MD, Alex Hong Chang, He Huang, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 34.
DOI: https://doi.org/10.1182/blood-2020-143239
Published: 2020
Journal Articles

Potent Anti-Tumor Activity of Bcma CAR-T Therapy Against Heavily Treated Multiple Myeloma and Dynamics of Immune Cell Subsets Using Single-Cell Mass Cytometry

Yongxian Hu, MD, Zhang Yanlei, Guoqing Wei, Chang alex Hong, He Huang
Journal: Blood
Blood (2019) 134 (Supplement_1): 1859.
DOI: https://doi.org/10.1182/blood-2019-130341
Published: 2019
Journal Articles

Galectin-9 from Bone Marrow Mesenchymal Stromal Cells Mediates Immunosuppression on Chimeric Antigen Receptor T Cells

Xinyi Teng, BS, Hao Zhang, MD, Zuyu Liang, MD, Mi Shao, MD, Xiujian Wang, MD, Lijuan Ding, MD, Jiazhen Cui, msc, Yongxian Hu, MD, He Huang, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5609.
DOI: https://doi.org/10.1182/blood-2019-131680
Published: 2019
Journal Articles

Pre-Transplant MRD Negativity Predicts Favorable Outcomes of CAR-T Therapy Followed By Haploidentical HSCT for Relapsed/Refractory Acute Lymphoblastic Leukemia: A Multi-Center Retrospective Study

Yongxian Hu, MD, Zhao Houli, Wei Guoqing, Yi Luo, MD, Ji Min Shi, Jing Chen, Zhang Qing, Song Xianmin, Lei Xiao, PhD, Alex Hong Chang, Didier Blaise, MD PhD, Mohamad Mohty, MD PhD, He Huang
Journal: Blood
Blood (2019) 134 (Supplement_1): 3213.
DOI: https://doi.org/10.1182/blood-2019-128399
Published: 2019
Journal Articles

Cytokine Release Syndrome Is an Independent Risk Factor Associated with Platelet Transfusion Refractoriness after CAR-T Treatment for Relapsed/Refractory Acute Lymphoblast Leukemia

Yadan Liu, graduate student, Yongxian Hu, MD, He Huang
Journal: Blood
Blood (2019) 134 (Supplement_1): 2448.
DOI: https://doi.org/10.1182/blood-2019-129678
Published: 2019
Journal Articles

Maintenance Sorafenib Is Superior to Prophylactic DLI in Improving the Prognosis of FLT3-ITD-Positive AML after Allogeneic HSCT

Jimin Shi, MD, Liqin Cao, MD, Yi Luo, MD, Yanmin Zhao, MD, Yamin Tan, MD, Jian Yu, MD, Xiaoyu Lai, MD, Yuanyuan Zhu, MD, Yongxian Hu, MD, Jingsong He, MD, Jie Sun, MD, Weiyan Zheng, MD, Guoqing Wei, MD, He Huang
Journal: Blood
Blood (2019) 134 (Supplement_1): 2668.
DOI: https://doi.org/10.1182/blood-2019-127594
Published: 2019
Journal Articles

Incidence and Risk Factors Associated with Infection after Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory B-Cell Malignancies

Feng Zhu, Yongxian Hu, MD, Wei Guoqing, He Huang, Wenjun Wu, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3220.
DOI: https://doi.org/10.1182/blood-2019-129649
Published: 2019
Journal Articles

Comparison between Hypercvad and CALLG2008 Protocol in Adult Patients with Newly Diagnosed Acute Lymphoblastic Leukemia:a Single Center Study

Yang Yingying, He Huang, Yongxian Hu, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5122.
DOI: https://doi.org/10.1182/blood-2019-129759
Published: 2019
Journal Articles

Therapeutic Effect of Platelet Transfusion in Patients with Acute Lymphocytes Treated with CART Therapy

Liu Yan, MD, Xie Jue, MD PhD, Yongxian Hu, MD PhD, He Huang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5073.
DOI: https://doi.org/10.1182/blood-2018-99-120108
Published: 2018
Journal Articles

Profile of Capillary-Leak Syndrome in Patients Received Chimeric Antigen Receptor T Cell Therapy

Yongxian Hu, MD PhD, Jingjing Feng, MD, Mi Shao, He Huang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5204.
DOI: https://doi.org/10.1182/blood-2018-99-117602
Published: 2018
Journal Articles

Changes of T Lymphocyte Subsets after CAR-T Cell Therapy and Its Clinical Significance

Lijuan Ding, Jiazhen Cui, Yongxian Hu, MD PhD, Huijun Xu, Yanlei Zhang, Shaohui Liu, Kangyan Wang, Zhenxing Guo, AlexH Chang, MD, PhD, He Huang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1423.
DOI: https://doi.org/10.1182/blood-2018-99-117885
Published: 2018
Journal Articles

Chimeric Antigen Receptor T-Cell Therapy Shapes T Cell Repertoire in Chinese Patients with B-Cell Acute Lymphocyte Leukemia

Xiujian Wang, Tao Sun, PhD, Yongxian Hu, MD PhD, Xiao Liu, PhD, Jian Yu, MD, Pengfei Xu, Guoqing Wei, MD, Chao Jin, Wenjun Wu, MD, Fu Huarui, MD, Lijuan Ding, Fang Ni, Hao Zhang, Zuyu Liang, Binsheng Wang, PhD, Xiaoqing Li, Cong Wei, Yunyun Deng, MS, Jimin Shi, MD, Lei Xiao, PhD, Zhao Wu, PhD, He Huang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1413.
DOI: https://doi.org/10.1182/blood-2018-99-115780
Published: 2018
Journal Articles

Quantification of Non-Hodgkin Lymphoma Disease Burden Using FDG PET-CT Helps Predict the Severity of Cytokine Release Syndrome

Jiasheng Wang, MD, Yongxian Hu, MD PhD, Yanlei Zhang, Guoqing Wei, MD, Huijun Xu, Wenjun Wu, MD, Shaohui Liu, Kangyan Wang, Zhenxing Guo, Alex Hongsheng Chang, Kui Zhao, He Huang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2997.
DOI: https://doi.org/10.1182/blood-2018-99-117983
Published: 2018
Journal Articles

Comparison of Chimeric Antigen Receptor T Cells from Allogenic or Autologous Sources in Patients with Acute Lymphoblastic Leukemia

Yongxian Hu, MD PhD, Jiasheng Wang, MD, Yanlei Zhang, Guoqing Wei, MD, Huijun Xu, Wenjun Wu, MD, Jian Yu, MD, Yi Luo, MD, Jimin Shi, MD, Shaohui Liu, Kangyan Wang, Zhenxing Guo, Alex HONGSHENG Chang, He Huang, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2691.
DOI: https://doi.org/10.1182/blood-2018-99-117910
Published: 2018